Identification of as a Gastric Fungus Associated with PD-L1 Expression and Overall Survival of Patients with Gastric Cancer.

J Immunol Res

Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Published: November 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Microbiotas affected the prognosis of cancer patients by regulating programmed death ligand-1 (PD-L1) expression. However, the relationship between gastric fungi and PD-L1 expression is still unclear in gastric cancer (GC). We aimed at exploring the association of gastric fungi with PD-L1 expression and overall survival in GC.

Methods: A total of 61 GC patients were divided into the two groups based on the PD-L1 combined positive scores (CPS). Fungal profiling was performed by internal transcribed spacer rDNA sequencing, and the survival analyses were performed by Kaplan-Meier curves.

Results: We observed a taxonomic difference of fungi between the PD-L1-High ( ≥ 10) and PD-L1-Low group ( < 10) by principal coordinates analysis (PCoA) ( = 0.014 for Bray-Curtis and = 0.042 for Jaccard). had a higher abundance in the PD-L1-High group compared to the PD-L1-Low group ( = 0.045). elevated significantly in the PD-L1-High group. GC patients with PD-L1 low expression and low abundance of had a longer overall survival (OS) than others ( = 0.047). was associated with PD-L1 expression (  = 3.509, 95% Confidence Interval: 1.056-11.656, = 0.040). was associated with the tumor size ( = 0.031) and PD-L1 status ( = 0.024). GC patients with a high abundance of had shorter OS than others ( = 0.028). was an independent factor (  = 3.080, 95% Confidence Interval: 1.140-8.323, = 0.027) for OS after adjusting for tumor stage. was figured out to be associated with- fatty acid and lipid biosynthesis and degradation via LIPASYN pathway. was identified as a PD-L1 expression-associated gastric fungus and associated with OS of GC patients, which calls for more studies to further explore its potential in PD-L1/PD-1 targeted immunotherapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669766PMC
http://dx.doi.org/10.1155/2022/2430759DOI Listing

Publication Analysis

Top Keywords

pd-l1 expression
20
pd-l1
9
gastric fungus
8
fungus associated
8
associated pd-l1
8
expression survival
8
gastric cancer
8
gastric fungi
8
fungi pd-l1
8
pd-l1-low group
8

Similar Publications

Background: The expression and clinical correlation of BRAFV600E mutation and programmed cell death-1 ligand 1 (PD-L1) in children with Langerhans cell histiocytosis (LCH) have been reported, but the conclusions of previous studies are inconsistent. In addition, it has been reported that elevated cathepsin S (CTSS) expression is associated with various cancers. However, there is currently no research on the correlation between CTSS and LCH.

View Article and Find Full Text PDF

Purpose: In Armenia, a lower-middle-income country, cancer causes 21% of all deaths, with over half of cases diagnosed at advanced stages. Without universal health insurance, patients rely on out-of-pocket payments or black-market channels for costly immunotherapies, underscoring the need for real-world data to inform equitable policy reforms.

Methods: We conducted a multicenter, retrospective cohort study of patients who received at least one dose of an immune checkpoint inhibitor (ICI) between January 2017 and December 2023 across six Armenian oncology centers.

View Article and Find Full Text PDF

Pancreatic cancer (PC) is notoriously resistant to both chemotherapy and immunotherapy, presenting a major therapeutic challenge. Epigenetic modifications play a critical role in PC progression, yet their contribution to chemoimmunotherapy resistance remains poorly understood. Here, we identified the transcription factor ZEB1 as a critical driver of chemoimmunotherapy resistance in PC.

View Article and Find Full Text PDF

Background: Hepatocellular carcinoma (HCC) frequently invades the portal vein, leading to early recurrence and a poor prognosis. However, the mechanisms underlying this invasion remain unclear. In this study, we aimed to detect portal vein circulating tumor cells (CTCs) using a Glypican-3-positive detection method and evaluate their prognostic significance.

View Article and Find Full Text PDF

Background: Trials of neoadjuvant chemoimmunotherapy (chemoIO) have changed the standard of care for resectable nonsmall cell lung cancer (NSCLC). This study characterizes the outcomes of off-trial patients who received treatment with neoadjuvant chemoIO.

Methods: The authors analyzed records of patients with stage IB-III NSCLC who received neoadjuvant chemoIO with an intent to proceed to surgical resection at three US academic institutions.

View Article and Find Full Text PDF